Abstract
The use of biologics targeted to the human epidermal growth factor receptor 2 (HER2) protein is the latest addition to the armamentarium used to fight advanced gastric or gastro-oesophageal junction...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have